SCHEMBL1866876

SCHEMBL1866876

OCC(O)C(O)C1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.44
KDM4E B2RXH2 2/20 0.43
LMNA P02545 2/20 0.43
GMNN O75496 1/20 0.43
MAPT P10636 1/20 0.43
BLM P54132 1/20 0.43
PMP22 Q01453 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
EPHX1 P07099 2/20 0.37
SHBG P04278 1/20 0.37
SLC6A2 P23975 2/20 0.37
SLC6A4 P31645 2/20 0.37
SLC6A3 Q01959 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.35
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1865857 0.97 TP53 (0.41) TP53KDM4ELMNAGMNNMAPT
Methyl Alcohol SCHEMBL6679734 0.95 TP53 (0.41) TP53KDM4ELMNAGMNNMAPT
SCHEMBL22631554 0.92 LMNA (0.36) TP53KDM4ELMNAGMNNMAPT
SCHEMBL28132635 0.87
SCHEMBL1868668 0.86 LMNA (0.43) TP53KDM4ELMNAGMNNMAPT
SCHEMBL1866970 0.83 LMNA (0.46) TP53KDM4ELMNAGMNNMAPT
SCHEMBL28121749 0.82 TDP1 (0.50) TP53KDM4ELMNAGMNNMAPT
SCHEMBL12634345 0.81 TP53 (0.37) TP53KDM4ELMNAGMNNMAPT
SCHEMBL10726111 0.80 TP53 (0.44) TP53KDM4ELMNAGMNNMAPT
Formaldehyde SCHEMBL28467533 0.80 LMNA (0.35) LMNAL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122094659-A Phospholipid-containing composition, cosmetic, and external preparation for skin 2026-05-26 CN claimed
EP-4743053-A1 ANTIMICROBIAL SYNERGIES Symrise AG (DE) 2026-05-20 EP claimed
US-20260102329-A1 BIOBASED POLYGLYCERYL ESTERS AND COMPOSITIONS COMPRISING THE SAME INOLEX INVESTMENT CORPORATION (US) 2026-04-16 US claimed
EP-4554551-B1 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS SYMRISE AG (DE) 2026-03-11 EP claimed
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent SYMRISE AG (DE) 2026-02-12 US claimed
EP-4616840-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-09-17 EP claimed
US-12415904-B2 Biobased glyceryl heptanoate ester compositions and methods of making and using the same INOLEX INVESTMENT CORPORATION (US) 2025-09-16 US claimed
US-20250270182-A1 Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound SYMRISE AG (DE) 2025-08-28 US claimed
EP-4103288-B1 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION SYMRISE AG (DE) 2025-07-30 EP claimed
EP-4582079-A2 COMPOSITIONS COMPRISING (BIO)-ALKANEDIOLS WITH ANTIMICROBIALS FOR PRODUCT PROTECTION Symrise AG (DE) 2025-07-09 EP claimed
EP-3100715-B1 COSMETIC COMPOSITION AJINOMOTO KK (JP) 2019-01-02 EP claimed
US-10117820-B2 Cosmetic composition AJINOMOTO CO., INC. (JP) 2018-11-06 US claimed
US-20180092357-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS ISP INVESTMENTS LLC (US) 2018-04-05 US claimed
EP-3288380-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS ISP Investments LLC (US) 2018-03-07 EP claimed
EP-3263093-A1 COSMETIC COMPOSITION AJINOMOTO CO., INC. (JP) 2018-01-03 EP claimed
CN-106214504-A Cosmetic combination 味之素株式会社 2016-12-14 CN claimed
US-20160354294-A1 COSMETIC COMPOSITION AJINOMOTO CO., INC. (JP) 2016-12-08 US claimed
EP-3100715-A1 COSMETIC COMPOSITION Ajinomoto Co., Inc. (JP) 2016-12-07 EP claimed
WO-2016164555-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS ISP INVESTMENTS INC. (US) 2016-10-13 WO claimed
US-5153179-A Mixtures of drugs with 1-alkylglycerols MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFT E.V. (DE) 1992-10-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270182-A1 Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound GK, DAGLA, KAT5 TP53 4780/4885KDM4E 66/4885LMNA 3505/4885
US-12415904-B2 Biobased glyceryl heptanoate ester compositions and methods of making and using the same SGMS1, MGLL, CCL11 TP53 2977/4885KDM4E 2584/4885LMNA 3468/4885
US-20260041094-A1 Compositions Comprising an Antimicrobial Boosting Agent TLR7, MYC, ERG28 TP53 1644/4885KDM4E 4297/4885LMNA 4342/4885
US-20160354294-A1 COSMETIC COMPOSITION KAT7, HDAC10, KAT5 TP53 794/4885KDM4E 2238/4885LMNA 4332/4885
US-20260102329-A1 BIOBASED POLYGLYCERYL ESTERS AND COMPOSITIONS COMPRISING THE SAME MGLL, LIPA, ELOVL1 TP53 3190/4885KDM4E 2479/4885LMNA 652/4885
US-20180092357-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS PIEZO1, CASP1, PRNP TP53 1047/4885KDM4E 3639/4885LMNA 45/4885
US-10117820-B2 Cosmetic composition KAT7, HDAC10, KAT5 TP53 794/4885KDM4E 2238/4885LMNA 4332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.